Renaissance Technologies - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 170 filers reported holding PTC THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,257
-98.1%
234,600
+4089.3%
0.01%
Q3 2022$281,000
-67.9%
5,600
-74.5%
0.00%
-100.0%
Q4 2021$876,000
-71.1%
22,000
-73.0%
0.00%
-75.0%
Q3 2021$3,036,000
-65.0%
81,600
-60.2%
0.00%
-63.6%
Q2 2021$8,666,000
-4.3%
205,010
+7.2%
0.01%0.0%
Q1 2021$9,053,000
+3329.2%
191,200
+3576.9%
0.01%
Q2 2020$264,000
-98.4%
5,200
-98.6%
0.00%
-100.0%
Q1 2020$16,925,000
+12.3%
379,400
+20.9%
0.02%
+33.3%
Q4 2019$15,077,000
+242.1%
313,900
+140.9%
0.01%
+200.0%
Q3 2019$4,407,000
-73.5%
130,300
-64.7%
0.00%
-73.3%
Q2 2019$16,608,000
-51.4%
369,060
-59.3%
0.02%
-51.6%
Q1 2019$34,151,000
-2.7%
907,300
-11.3%
0.03%
-18.4%
Q4 2018$35,099,000
+164.3%
1,022,700
+261.9%
0.04%
+171.4%
Q3 2018$13,282,000
+123.9%
282,600
+28.9%
0.01%
+366.7%
Q2 2018$5,932,0000.0%219,2000.0%0.00%
-50.0%
Q1 2018$5,932,000
+56.9%
219,200
-3.3%
0.01%
+50.0%
Q4 2017$3,780,000
-51.2%
226,600
-59.0%
0.00%
-71.4%
Q3 2016$7,743,000
+982.9%
552,700
+442.4%
0.01%
+1300.0%
Q2 2016$715,000
-88.3%
101,900
-89.3%
0.00%
-91.7%
Q1 2016$6,110,000
+247.2%
948,700
+1339.6%
0.01%
+200.0%
Q3 2015$1,760,000
+211.5%
65,900
+205.1%
0.00%
+300.0%
Q2 2014$565,00021,6000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders